🔎 Trials Near Me

Akèy › Kansè nan tete › South Carolina › Charleston

Etid klinik pou Kansè nan tete nan Charleston, SC

12 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Charleston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

CBD for Breast Cancer Primary Tumors

Ap rekriteFaz 1
  • Medical University of South Carolina, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06148038

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Ap rekriteFaz 3
  • Medical University of South Carolina-Hollings Cancer Center ( Site 0016), Charleston
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06966700

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Ap rekriteFaz 3
  • Medical University of South Carolina, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07174336

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Ap rekriteFaz 3
  • Hollings Cancer Center, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06492616

E-Mindfulness Approaches for Living After Breast Cancer

Ap rekriteFaz 3
  • Medical University of South Carolina, Charleston
Laj 18 a 50 · Tout sèks · Mizajou Aug 4, 2026 · NCT06748222

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Ap rekriteFaz 2
  • Medical University of South Carolina, Charleston
Laj 18 a 55 · Fanm · Mizajou Jul 27, 2026 · NCT06184750

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

Ap rekriteFaz 2
  • Medical University of South Carolina, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Apr 29, 2026 · NCT04468061

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Ap rekriteFaz 3
  • Medical University of South Carolina, Charleston
Laj 50 a 70 · Tout sèks · Mizajou Apr 23, 2026 · NCT04852887

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Ap rekriteEtid obsèvasyon
  • Medical University of South Carolina, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Medical University of South Carolina, Charleston
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Ap rekriteEtid obsèvasyon
  • Roper St. Francis Physician Partners - Breast Surgery, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2025 · NCT03053193

Etid Kansè nan tete nan lòt vil

Lòt etid nan Charleston

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.